April 26, 2022
Medical Research
AMRA Medical’s MRI-based body composition measurements used in Lilly’s SURPASS-3 tirzepatide sub-study
Eli Lilly and Company assessed the impact of tirzepatide, an investigational therapy for the treatment of type 2 diabetes, on liver fat, visceral fat,…